Achinger-Kawecka, Joanna <br/><br/>
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.  [electronic resource] 

 -  Nature communications  01 2020 
 - 320 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-019-14098-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--pharmacology<br/>Binding Sites<br/>Breast Neoplasms--genetics<br/>CCCTC-Binding Factor--chemistry<br/>Chromatin--chemistry<br/>DNA Methylation<br/>Epigenesis, Genetic--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>MCF-7 Cells<br/>Neoplasm Proteins--genetics<br/>Promoter Regions, Genetic--drug effects<br/>Protein Interaction Domains and Motifs<br/>Receptors, Estrogen--chemistry<br/>Whole Genome Sequencing